Crown ElectroKinetics (NASDAQ:CRKN) reported quarterly losses of $(0.18) per share. This is a 53.85 percent increase over losses of $(0.39) per share from the same period last year.
Novo Nordisk’s Mim8 Shows Potential As Once Monthly Treatment For Hemophilia A
Novo Nordisk A/S (NYSE:NVO) announced that the phase 1 & 2 FRONTIER1 dose-escalation study in treating people with hemophilia…